Zoetis has announced that the European Commission has granted marketing authorization for Simparica™ (sarolaner) chewable tablets, a once-monthly medication for the treatment of fleas, ticks and sarcoptic mange in dogs beginning at eight weeks of age.
Dr. Balázs Capári, a Hungarian veterinary specialist in small animal medicine who participated in clinical trials of Simparica said: "The approval of Simparica gives veterinarians a new oral choice in parasite control for dogs. In my experience, Simparica has been shown to rapidly kill fleas and ticks with efficacy that persists for five weeks. Dog owners participating in the trials also reported that Simparica is very palatable; the chewable tablet was easily taken by their dogs. The convenience of a once monthly chewable tablet helps increase compliance with treatment, giving veterinarians and dog owners confidence in continuous protection."
Dr. Catherine Knupp, Executive Vice President and President, Research and Development at Zoetis, said: "At Zoetis, we focus our innovation on the most pressing needs of veterinarians, and that is what guided us to develop a new oral choice to provide dogs with persistent protection from fleas and ticks and treatment of mites that cause sarcoptic mange. Simparica is a result of the collaboration of Zoetis scientists worldwide, who share a determination to develop new medicines that deliver real value to our veterinary customers and the animals in their care. We are excited to bring this innovative medicine, Simparica, to veterinarians and dog owners across Europe."
The active substance of Simparica is sarolaner, a new ectoparasiticide in the isoxazoline class, developed by Zoetis.
Zoetis says the marketing authorization for Simparica was based on the results of field studies conducted in seven countries, involving more than 800 dogs of various breeds from at least eight weeks of age and 1.3 kg of weight. Simparica was shown to provide efficacy for at least five weeks against ticks and fleas. It demonstrated a rapid onset of action, killing fleas before they have a chance to lay eggs and can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis. It proved effective in treating sarcoptic mange, a highly contagious skin disease in dogs.
In studies, Simparica killed all four species of tick dominant in Europe (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus) and species of flea that most frequently infect dogs in European countries (Ctenocephalides felis and Ctenocephalides canis). Simparica was well tolerated with no adverse events reported at the therapeutic dose.
Zoetis expects to launch Simparica in the EU in the first quarter of 2016. Simparica chewable tablets will be available in 5mg, 10mg, 20mg, 40mg and 80mg dosage strengths.
For more information about Simparica and full prescribing information, visit http://www.zoetis.com/products-services/companion-animals/dogs.
The Equine Veterinary Journal (EVJ) has published a free online collection of articles which explain the current understanding of equine antimicrobial resistance and how the profession can preserve the effectiveness of these essential medicines.
The new collection comprises ten clinical reports and studies and three editorials covering current trends on bacterial populations, risk factors and the appropriate use of antimicrobials in practice.
A clinical report on the changes in bacterial populations in foals with sepsis raises the question whether the emergence of resistance in horses has occurred as a result of antibiotic use in humans, with nosocomial spread from human handlers in foals. Studies on the prevalence of faecal carriage of antimicrobial resistant E. coli show their prevalence to be common in normal horses in the community in the UK, although MRSA carriage was rare. Data suggested transmission of resistant bacteria from animals receiving antibiotics may result in carriage of bacteria by in contact animals.
The need for judicious use of antimicrobials is reinforced in a study on antimicrobial-associated diarrhoea in three equine referral practices. Two papers investigate both prescribing practice in the UK and the impact of antimicrobial use on infection and pyrexia in hospitalised horses, concluding that there are opportunities for more targeted, ‘smart’, use antimicrobials in the perioperative period, rather than simply more antimicrobials.
The final study discusses a low-cost syndromic surveillance model for monitoring healthcare associated infection in clinical practice to provide a realistic benchmark against which other hospitals may compare antimicrobial study data.
Three supporting editorials complete the online collection, giving comment on the overall situation of antimicrobial resistance in the horses, including the current political situation and antimicrobials and surgical site infection.
Professor Peter Clegg, Associate Editor of the Equine Veterinary Journal said: "It remains to be determined how big a problem antimicrobial resistance will become for the equine veterinary profession, either through greater difficulties in treating horses, or through political pressure to restrict access to antimicrobials. Meanwhile the EVJ remains committed to the promotion of responsible stewardship to best preserve the efficacy of the drugs we have got for as long as we can."
Mark Bowen, President of the British Equine Veterinary Association and guest editor said: "BEVA has a long-term commitment to promoting responsible antimicrobial use throughout the profession and supporting EAAD through the PROTECT ME brand. This year we have released resources around Education, aimed at the profession through EVJ and to the horse owning public through development of material that can be provided alongside antimicrobial dispensing. The work of the equine profession in preserving the highest priority antimicrobials will ensure efficacy can be retained for as long as is possible."
The antimicrobial online collection is available free online at: http://onlinelibrary.wiley.com/journal/10.1001/(ISSN)2042-3306/homepage/antimicrobial_resistance.htm
Dr Johanna Fink-Gremmels – Professor of Veterinary Pharmacology and Toxicology at Utrecht University – has warned that UK cattle producers need to plan for an on-going struggle with feed-borne mycotoxins, and says vets need to help farmers understand and mitigate the negative impact on animal health.
Speaking to cattle vets at a CPD meeting organised by Alltech, she said: "When you see a general inflammatory response, such as elevated somatic cell count, mycotoxicosis should always be on your radar. The mycotoxin threat to cattle is increasing in the UK, yet it is often the most neglected causative issue on any list of pathogenic suspects."
Johanna explained that natural toxins produced by diverse fungal species are proliferating worldwide, partly as a result of global climate change, but also because of changing agronomic practices in developed countries.
"Total mixed rations often now contain more than one fungal species, contributing to a complex mycotoxin picture and unresolved health issues in a herd as a result. Cow signals such as reduced feed intake, reproductive disorders, laminitis, mastitis, impaired liver function, a poor response to vaccination programmes and even increased susceptibility to bacterial and viral diseases can all be attributed to ingesting mycotoxin contaminated feed."
Johanna says the biggest challenge for UK dairy farmers is now multiple mycotoxin contamination of grass and maize silage.
"Cattle health problems with feeding obviously mouldy silage are relatively well understood. But new harder to detect fusarium toxins – such as, for example, Enniatins and Beauvericin contaminating cereal grains – are also now being found in pasture grass in Northern Europe. These will also adversely affect the efficiency and function of the rumen.
"The rumen determines the health and productivity of the cow. When rumen bacteria are suffering the liver does not function correctly initiating a cascade of adverse events; and often a generalised inflammatory response is triggered, which leads to a loss of production."
Johanna added that in the future farmers will need select feed crop plants that are more resistant to fungal invasion and will also have to re-adjust tillage methods to reduce mould contamination. "However, we know that this alone will not stamp out mycotoxin contamination without creating a biological vacuum that will be filled with other micro-organisms.
"Consequently, it will be essential to continue to apply strategies such as rigorous on-farm risk assessment and the use of appropriate in-feed mycotoxin-sequestration agents (binders) to prevent the production-limiting and adverse health effects in our farmed livestock."
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
The RCVS has launched the new Practice Standards Scheme (PSS), which is now open for applications for both practice accreditations and the new system of PSS awards.
Speaking after today’s launch at the London Vet Show, which over 200 veterinary surgeons, veterinary nurses and practice managers attended, Practice Standards Group chair Jacqui Molyneux, said: "The new Scheme is all about offering a pathway to improvement for practices of all shapes and sizes that want to aspire to excellence, and then highlighting these achievements to the animal-owning public in a way that is clear and easy to understand.
"Over half of all veterinary practice premises in the UK are already RCVS-accredited, which is fantastic for a voluntary scheme, but we’d really like to help more practices to get on board. I hope that the improvements and exciting new benefits that we’ve developed will make the Scheme even more rewarding for existing members, and encourage more people to join."
The College says that the main changes to the scheme have been based on feedback from the profession and input from the Practice Standards Group (PSG), with the dual aims of making it more accessible for those practices which aren’t yet PSS members, and even more rewarding for those who are already accredited.
Whilst retaining the existing accreditation levels across small animal, equine and farm animal practices (current RCVS-accredited practices will be automatically transferred to the new Scheme), a new modular structure helps to make the Scheme more flexible and ensure all types of veterinary practice – from ambulatory services to veterinary hospitals – can join. This structure also recognises the contributions of the whole practice team, helping to raise standards across the board.
Once accredited, practices can now apply for a range of optional awards that focus on outcomes and behaviours in specific areas, such as ‘In-patient Service’, ‘Team and Professional Responsibility’ and ‘Client Service’. Designated at either ‘Good’ or ‘Outstanding’, these awards should help clients understand where a practice excels, and what skills and services are on offer, enabling them to make choices based on their needs and preferences.
The RCVS has also recruited and trained a new team of assessors, who will take more of an interest in listening to practice staff rather than just checking paperwork and equipment. It has also developed an online administration and support tool – nicknamed Stanley – to provide document storage, a calendar and a self-assessment function, to make the accreditation and awards application processes quicker and easier to manage.
As an introductory offer, the RCVS is now inviting applications from practices that would be willing to help with a final round of testing of the new Scheme, to be in with a chance to win one of 20 free assessment days, worth £350. The offer is open until Friday 4 December, and the first 20 practices drawn at random on 7 December will be allocated the free assessments.
Full details about the draw, the new Scheme and how to apply for accreditation and/or awards are available at www.rcvs.org.uk/newpss. The new promotional video shown above can also be viewed here.
The RCVS and the BVA have published the Vet Futures report: their vision for how the veterinary profession should look in 2030, coupled with 34 recommendations for change.
The report, which represents the culmination of a year of engagement, consultation and research with the veterinary profession, veterinary nurses, members of the wider veterinary team, key stakeholders, animal owners and the general public, says that in 2030 vets should be a leading force for animal health and welfare and valued for their wider roles in society. They should be confident, resilient, healthy and well supported, and benefit from exceptional leadership. And there should be a broad range of diverse and rewarding veterinary careers, as well as thriving, innovative and user-focused businesses.
While the focus of Vet Futures has been on veterinary surgeons, Vet Futures engaged with the RCVS Veterinary Nurses Council and British Veterinary Nursing Association, as well as individual veterinary nurses, and the College says that many of the ambitions should resonate with members of both professions. It goes on to recommend that the veterinary nursing profession should build on the work of Vet Futures to develop its own clear vision and ambitions.
The recommendations within the report include:
Other recommendations include developing an animal welfare strategy for the profession, increasing collaboration with medical professionals and environmental organisations, adopting a more strategic long-term outlook for research funding, and exploring how to encourage a more diverse profession.
RCVS President Bradley Viner said: "The Vet Futures report is the culmination of a year of research and engagement with thousands of members of the veterinary and veterinary nursing professions, which has given us a very firm foundation on which to build our ambitions and recommendations. We are extremely grateful to every individual who has contributed in some way to the project, and helped us to seize the initiative.
"Over the years the veterinary profession has proved itself to be adaptable and able to face challenges head on, and we have no doubt that by working together we will realise our joint vision of a profession in charge of its future. Ultimately, we all want a profession that is confident in itself and one in which members are proud to call themselves veterinary surgeons."
Sean Wensley, BVA President, added: "Vet Futures has proved to be an exciting, engaging and truly ambitious project for the veterinary profession and it has created a fantastic level of debate and engagement.
"The report we are launching today is not the end of the story; it is the beginning of the next chapter. It is crucial that we maintain the momentum of the project so we will be inviting members of the veterinary professions to step forward and join a new Vet Futures Action Group to help us turn the recommendations into actions and drive forward activity."
The full report can be downloaded here.
Lindsay Newell, a Derbyshire veterinary nurse, has been struck off by The Veterinary Nurses Disciplinary Committee of the RCVS, after she was found guilty of the unlawful possession of veterinary medicines and failing to give regard to welfare in respect of six animals.
The hearing for Ms Newell, who did not attend and was not represented, concluded on 18th November 2015. It related to two main charges against her. The first was that, on 29 November 2012, she was found in possession of a number of veterinary medicines without lawful permission.
The Committee heard that the RSPCA and police officers had attended Ms Newell’s home on that day, where they found veterinary medicines, including controlled drugs, stored in an insecure cabinet within an insecure shed. It heard that during a police interview, she agreed that she was not allowed to possess some of the drugs and subsequently accepted a police caution, which the Committee took as an admission of the offence and therefore found the charge proved.
The second charge was that, between 1 and 29 November 2012 at the Burton Wildlife and Rescue Centre in Etwall, Derbyshire, she failed to give any or sufficient regards to the welfare of six animals in her care. These charges relate to an RSPCA investigation of the rescue centre on 29 November 2012 which found two animals dead and the rest of the animals emaciated and in poor physical condition.
The animals included a male lamb found dead in its pen, a ‘furry-faced’ lamb which died just over a week after the investigation took place, a female goat which died 12 hours after being taken to a veterinary practice for treatment and a pig which died during the investigation process, as well as an adult ewe and a pony which both survived. The charge against her also cited her failure to supply an adequate diet, obtain any or any adequate veterinary attention and explore and address the cause of the weight loss for these animals.
The Committee found all parts of the second charge proved and was satisfied that Ms Newell failed to give sufficient regard to animal welfare as is required by the RCVS Code of Professional Conduct for Veterinary Nurses.
In deciding its sanction, the Committee considered a number of aggravating factors in this case. It found that, in respect of both charges, the misconduct was “sustained over a period of time rather than being a single and isolated incident” and that, in respect of the second charge, that there was “actual harm caused to animals, which resulted in the deaths of four out of the six animals.”
The Committee felt that this constituted reckless disregard for animal welfare rather than deliberate acts but, nevertheless, said that these animals unnecessarily suffered for a period of at least four weeks due to inadequate diet and that, as rescue animals that were already vulnerable, the expectation was that they would be given the appropriate level of care. It also found that Ms Newell had demonstrated limited insight into her behaviour. Furthermore, it considered that a Magistrates’ Court had also disqualified Ms Newell from keeping sheep, goats, pigs, and equines for a period of five years.
In mitigation it considered that Ms Newell did show some insight into her behaviour in relation to the first charge by making admissions during her police interview, as well as the fact that the animal sanctuary, which opened in 2008, had no complaints or cause for concern prior to 2012.
Ian Green, chairing the Committee and speaking on its behalf, said: “The Committee is of the opinion that removal of Ms Newell’s name from the Register of Veterinary Nurses is the only appropriate sanction based upon the severity of the facts found proved.”
Langford Veterinary Services, a fully owned subsidiary of the University of Bristol, has announced the opening of a new standing equine magnetic resonance imaging (MRI) facility at the university's equine centre.
The equine MRI facility completes the diagnostic imaging facilities in the School, which include a 16-slice CT scanner for small animals and standing horses, digital radiography, high-resolution fluoroscopy, diagnostic ultrasound, echocardiography and scintigraphy with a high-resolution 1.5 tesla MRI scanner, available seven days a week.
Evita Busschers, Senior Teaching Fellow and orthopaedic surgeon in the equine centre, said: “We are very grateful to the Trustees of the Alborada Trust and the Langford Trust who have provided generous support for the MRI facility. The new imaging facility will enable us to provide an even better and more complete service for our equine patients and completes the diagnostic imaging facilities available at the centre.
“Equine MRI offers the ability to image soft tissue structures and identify soft tissue injuries that cannot be demonstrated with other diagnostic imaging modalities and therefore has major additional value in providing a diagnosis and prognosis in lameness evaluations.”
Miles Littlewort, a trustee from the Alborada Trust added: “Donating the money is the easy bit but ensuring that it has been used where it should be and that it has made the necessary difference is much more challenging. We are so pleased to have had the opportunity to support the Langford Trust and their work to improve animal health and welfare. We are delighted to have attended the opening, to meet the clinicians who will use the magnificent facility and to learn about the clinical research which gives all veterinary surgeons evidence-based information to enhance diagnosis and treatment for all patients.”
Dechra Veterinary Products has launched TAF Spray (thiamphenicol), a next generation antibiotic wound spray for superficial wound infections in horses, cattle, goats, sheep and pigs.
Dechra says TAF Spray can also be used to treat infections of the claw and hoof in cattle, goats and sheep such as foot rot, interdigital dermatitis and digital dermatitis.
TAF Spray is the only licensed wound spray for horses and has a zero day meat withdrawal period for horses, cattle, goats, sheep, and 14 days for pigs.
Dechra is also highlighting the fact that TAF Spray is the only golden yellow coloured product of its kind on the market, allowing treatment areas to be distinguished clearly.
Brand Manager Emma Jennings said: “Dechra has developed TAF Spray in direct response to the research we conducted among farmers".
The research1 showed that 51% of the veterinary surgeons had used an antibiotic spray for the treatment of digital dermatitis – an infection that 92% of farmers had experienced in their livestock in the past 12 months.
Emma added: "Thiamphenicol is a highly effective antibiotic. With the brightly coloured spray format making it distinguishable from other treatments and a can that is able to be used in upright and inverted positions, we are sure that TAF Spray will become a popular product among veterinary professionals.”
TAF Spray comes in a 150ml can with a 360-degree nozzle which allows wounds to be targeted at any angle.
For further information about Dechra’s antibiotic portfolio, visit www.dechra.co.uk
Reference
The London Vet Show, which takes place on Thursday 19th November and Friday 20th November at the Olympia Grand, has announced the business programme for 2015.
The programme will include:
Rob Chapman, group event director of the London Vet Show and France Vet said: "The business programme at the London Vet Show has gone from strength to strength with a plethora of informative lectures from top class industry leaders. The informative content includes hints and tips that veterinary professionals can utilise in practice to help enhance their veterinary teams, increase profits and develop their business.”
For further information on the business programme at the London Vet Show or to register for the show visit londonvetshow.co.uk/business.
The RCVS has announced the new recruits for the two independent statutory committees responsible for investigating and holding inquiries into concerns raised about the professional conduct of veterinary surgeons.
The Disciplinary Committee has seven new members (three laypeople and four veterinary surgeons) and is now chaired by Ian Green, a former magistrate and Chief Executive of YMCA England from 2008 to 2013, who has been a member of the Committee since 2013.
The new members are:
The Preliminary Investigation Committee has three new members (all of them veterinary surgeons) and is now chaired by Andrew Ash MRCVS, a director of a veterinary practice group and Past-President of the British Small Animal Veterinary Association (BSAVA), who has been a member of the Committee since 2013. The new members are:
The College says these changes now bring it into line with a Legislative Reform Order which came into effect in July 2013 and which amended the Veterinary Surgeons Act to say that the two statutory committees should be constituted separately from RCVS Council.
Gordon Hockey, RCVS Registrar, said: “We pushed forward the LRO because we wanted to make sure that the College was following regulatory best practice by ensuring the independence of those who adjudicate on concerns raised about a veterinary surgeon’s professional conduct and fitness to practise.
“The LRO allowed for a two-year transitional period and so, with these new appointments, we see it come to fruition as the committee members are now wholly separate from RCVS Council members, who are ineligible to sit on the Disciplinary or Preliminary Investigation committees.
“I would like to extend a very warm welcome to the new Chairs and members of the committees. They all went through a rigorous recruitment process over a number of months this year and I am confident in their integrity, independence, judgement and abilities.”
Through the same independent recruitment process two new members have also been appointed to the VN Preliminary Investigation Committee – Suzanne May RVN and Susan Macaldowie MRCVS.
Details of the Disciplinary and Preliminary Investigation committees can be found at www.rcvs.org.uk/about-us/committees/disciplinary-committee and www.rcvs.org.uk/about-us/committees/preliminary-investigation-committee respectively.
Teeside veterinary nurses Debbie Rowley and Karen Taylor from Wilton Vets made history yesterday when they were called out to catch a 6ft, 18lb python spotted by the side of the road by a motorist in Guisborough.
Talking to the Guisborough Gazette, Debbie said: "We were shocked it was so big."
The snake is apparently in good shape, and now in the care of Kirkleatham Owl Centre.
Anyone missing a 6ft ft python is asked to contact Cleveland Police on 101.
Dechra Veterinary Products has launched a 5 ml bottle of Comfortan (methadone), its titratable analgesia for cats and dogs.
The new sized bottle of Comfortan, designed for use with animals in, or about to experience, moderate to severe pain, is now available from veterinary wholesalers.
Dechra Brand Manager Craig Sankey said: “The new 5ml bottle is a great size for practices which would like to introduce Comfortan into their practice protocols, allowing them to do so in a cost-effective way.
“The availability of a smaller bottle will also be a benefit to practices which due to different surgical needs, currently only use Comfortan in a small number of cases. They will then be able to simply and easily trade up to the 10 ml bottle once they start to use Comfortan on more cases.”
The 5 ml has also been introduced in response to demand from branch practices which had been transferring 10ml bottles between sites and for cat-focused practices which use smaller volumes of the product.
Bayer Animal Health has announced the launch of, Dinalgen (ketoprofen), an NSAID injection approved for use in cattle, pigs and horses.
Dinalgen is available as a 150mg/ml Solution for Injection, and Bayer says the more concentrated format allows the product to provide the smallest dose, fast relief NSAID currently available for cattle in the UK.
In cattle, Dinalgen is licensed for the reduction of inflammation and pain associated with lameness, post-partum, and musculoskeletal disorders; the reduction of fever associated with bovine respiratory disease; and the reduction of inflammation, fever and pain in acute clinical mastitis in combination with antimicrobial therapy where appropriate. The withdrawal period for milk is zero hours and for meat two days.
In pigs, Dinalgen is licensed for the reduction of pyrexia in cases of respiratory disease and postpartum dysgalactia syndrome in sows, in combination with antimicrobial therapy.
In horses, Dinalgen is licensed for the reduction of inflammation and pain associated with osteoarticular and musculoskeletal disorders, including lameness, laminitis, osteoarthritis, synovitis, and tendinitis. It also aids the reduction of visceral pain associated with colic.
Sharon Cooksey, MRCVS, FAP group product manager at Bayer, said: “We are excited to have this new addition to our portfolio. It is a good fit with our existing products.
"A recent field study*, carried out by Nottingham university, has shown that NSAID (ketoprofen) treatment maximises the chance of recovery from lameness in dairy cattle. Lameness remains one of the “big three” issues in dairy practice so maybe it is time we moved on from hoof blocks and/ or trimming in isolation and onto a more multi-layer approach. We have some great support tools in the pipeline to help both vets and farmers recognise and manage animals at risk for lameness.”
For further product information visit www.noahcompendium.co.uk or contact your local Bayer territory manager.
Research published online in the Veterinary Record has revealed that one in four dogs competing in Crufts is overweight, despite the perception that entrants are supposed to represent ideal specimens of their breed1.
The researchers based their findings on 1120 online images of dogs from 28 breeds —- half of which are prone to obesity — that had appeared at Crufts, the largest dog show of its kind in the world.
Only adult dogs that had been placed between first and fifth in their class between 2001 and 2013 were included in the study.
The images were coded and anonymised, and 960 were deemed suitable for assessment. A second person then graded the body condition of each dog in one sitting, using a previously validated method. One in four (252; 26%) was found to be overweight.
Pugs, basset hounds, and Labrador retrievers were the breeds most likely to be assessed as being overweight. Dogs were overweight in 80% of the pug images, 68% of the Basset Hound and 63% of the Labrador images.
The researchers said that the three breeds with the highest prevalence of being overweight among the online images are prone to excess weight. Nevertheless, since pugs were originally bred to be a companion dog, while hounds and Labradors were bred for hunting and fieldwork respectively, being overweight would not be advantageous.
Standard poodles, border terriers, Rhodesian ridgebacks, Hungarian vizlas and Dobermanns were the least likely breeds to be overweight.
The prevalence of being overweight among the show dogs was less than that reported generally for pet dogs in the UK. Nevertheless, the researchers say the fact that a quarter were above ideal weight is still a cause for concern: “These dogs showcase the ideal characteristics of the pedigree breed, and there is a danger that widespread media exposure might adversely influence owner perception of optimal body shape.”
The Kennel Club has recently introduced changes in policy for judging criteria, to emphasise characteristics that promote good health in dogs. However, the researchers say that breed standards of optimal condition should be reinforced for competition, to ensure consistency: “Further effort is now required to educate owners, breeders and show judges so that they can all better recognise overweight condition, thus helping to prevent the development of obesity.”
Best in show but not best in shape: a photographic assessment of show dog body condition doi 10.1136/vr.103093
Virbac has launched Prinovox, a new prescription-only spot-on ectoparasiticide for dogs and cats.
The company says the new product contains the same combination of Moxidectin and Imidacloprid as the market leader, but is offered with a unique and innovative pet owner engagement programme to help practices build loyalty, increase compliance and to encourage repeat purchase.
In dogs Prinovox is licensed for the treatment and prevention of lungworm; for the treatment and prevention of fleas and also for lice, mites, heartworm and roundworms. In cats, the licence covers fleas, mites, roundworm and heart worm. It can also be used for fleas and heartworm in ferrets.
Prinovox is available in six presentations to suit all weight ranges and in packs of four pipettes. The packaging uses the Blippar platform which owners can use to 'blip' interactive icons on the product's packaging with their smartphone to get more information on Prinovox, including a video on how to use it, a reminder system and a game.
In addition, the Prinovox support package includes:
Virbac's Head of Marketing Companion Animal, Simon Boulton MRCVS said: "We see the launch of Prinovox as a gamechanger. The ectoparasiticide market is one of the largest and most competitive in our industry and we are the first company to offer a product with the same efficacy as the market leader for all indications.
"We've gone one step further by increasing the value of the product to practices by developing a comprehensive parasite protection support package which harnesses the latest technology and consumer preferences for receiving information. We believe the efficacy of Prinovox, combined with the innovative support package we're offering, will make it a highly attractive product for practices and owners and we've been delighted at the feedback we've received so far."
Zoetis has launched a new high precision treatment gun for single-handed low volume subcutaneous injections.
The gun handles medications up to 5ml per treatment. The company says it is designed for use with its long acting moxidectin injectable wormer and clostridial vaccines specifically, but is also suitable to other low dose medications administered subcutaneously
Zoetis vet Dave Armstrong said: "One-handed operation enables quicker treatment, better sheep welfare as a result of eliminating needle bending or breakage, and lower risk of self-injection by the operator."
As an indication of operator risk, Zoetis points to a report from one staff nurse working just 30-hours a week at a West Midlands hospital's A&E department, who dealt with three incidents of wormer self-injection in 20141.
Single-handed operation is made possible by a serrated needle guard that creates a skin fold into which the needle penetrates. Mr Armstrong says development of the gun is part of Zoetis's commitment - "as much as necessary, as little as possible" - towards helping farmers strengthen their effective and responsible use of animal medicines. He emphasises that for precision medicines to be exploited fully and responsibly, precision instrumentation is essential.
To accompany the gun, two detailed advisory booklets covering treatment techniques and equipment maintenance have also been published, covering a number of different designs including different volume injectors, pour-on applications and drenching guns. Copies are available free of charge to farmers from POM VPS medicine suppliers.
Improve International has announced that several of the Postgraduate Certificate programmes (PgC's) which it delivers in conjunction with Harper Adams University and the European School of Veterinary Studies (ESVPS) have been added to the list of qualifications conferring eligibility for applications for RCVS' Advanced Practitioner status.
The qualifying PgCs are:
These PgC's are accredited at Masters level 7 and provide 60 credits, at least 40 of which are in the designated clinical area. Improve says this places them at the same academic level as those offered by other CPD providers and termed as eligible entry qualifications to RCVS Advanced Practitioner Status.
Improve has welcomed the RCVS' decision to include these PgC's in the list of entry qualifications accepted with no further requirements required. For the PgC Small Animal Surgery and PgC Small Animal Medicine programmes, a further demonstration of professional key skills is required within a five-year period, which the company says it can help with.
David Babington MRCVS, Managing Director, said: "Our clinical taught programmes are led by experts in their field while the European School of Postgraduate Studies (ESVPS) has responsibility for the associated assessments. Harper Adams University brings the Higher Education body quality assurance to our partnership, ensuring that our qualifications meet the strict criteria laid down by the QAA Framework.
"Our programmes utilise a combination of review lectures, case-based discussions and, where applicable, hands-on practical sessions. We are also increasingly offering courses using 'blended learning', a format which combines both face to face and online learning.
"We are delighted that the RCVS has recognised that the content and rigour of the PgC programmes, make them deserving of the same status as other qualifications awarded by other providers. Our delegates can now have full confidence that achieving one of these postgraduate certificates will enable them to meet the requirements of Advanced Practitioner status."
For more information, see the RCVS website, Advanced Practitioner Guidance Notes, visit www.improveinternational.com or call 01793 759159.
Centaur Services has launched a range of health supplement soft chews for cats and dogs which can be ordered in custom, practice-branded packaging.
Centaur says the practice branding is designed to reinforce client relationships by encouraging clients to buy vet-recommended products direct from the practice, thereby reducing the loss of sales to the high street or online stores.
The chews consist of a flavoured base with a crumbly texture, into which various health supplements are blended. Centaur says they are particularly popular with owners who find it difficult to encourage their pets to consume supplements within harder carriers, as the soft chews are more akin to food and easier for the animals to consume.
Colm McGinn, Sales and Marketing Director of Centaur Services, said: "We're always looking for ways to innovate the offer we provide to our customers and make their businesses more successful. Not only are the chews a high quality product with excellent health benefits for pets, they also offer practices a new way of engaging with their clients by providing own-labelled products that come not only with the recommendation of their vet but also the trusted brand of the practice."
The chews are launching in five varieties. For dogs, there's joint support and a heart-shaped multi-vitamin. For cats, there's joint support, bladder support and hairball relief. Additional varieties are in development.
For more information call Centaur Services on 01963 350005 to arrange a visit, or for existing customers, contact your Territory Manager.
The Welsh Government Deputy Minister for Farming and Food, Rebecca Evans, has officially opened the new Wales Veterinary Science Centre.
The centre, which is located on the site of the former Animal and Plant Health Agency's (APHA) Veterinary Investigation Centre, has been established by Iechyd Da, a consortium of independent veterinary practices based in Wales together with Welsh Lamb and Beef Producers Ltd, and Aberystwyth University.
Iechyd Da was recently appointed by APHA as a third party provider to deliver expert post-mortem examinations of new and re-emerging diseases of farm animals. The service has been operational since April 2015.
Deputy Minister Rebecca Evans AM said: "I am pleased to officially open the Wales Veterinary Science Centre, which will significantly strengthen and enhance the important contribution the veterinary profession makes to rural life in Wales and raises standards of animal health and welfare. It will also bolster the rural economy by securing technical jobs for the area, benefit the wider economy by supporting our farming communities, and be an asset to the UK by contributing valuable data to the surveillance network."
Professor Christianne Glossop, Chief Veterinary Officer for Wales said: "The Centre will have a significant role in the protection of animals in Wales and will provide an important contribution to a successful and resilient farming industry, reflecting the essential role of the veterinary profession in Wales."
Phil Thomas, Director of Iechyd Da said: "Iechyd Da now looks forward to building on the post-mortem provision already available so that we can provide a range of services, from running training courses for animal keepers to dissection classes for students, continuous professional development for practicing vets, and supporting disease eradication schemes. The vision is of a One Health institute that recognises the interlocking, overlapping relationships between people, livestock, the wildlife and the environment around us."
Richard Irvine, Head of Scanning Surveillance and the Surveillance Intelligence Unit at the Animal and Plant Health Agency (APHA) said: "I look forward to APHA working in close partnership with the Wales Veterinary Science Centre to provide expert diagnostic support and surveillance intelligence for veterinary practices and farmers in Wales. Only by working together can we create an effective disease surveillance network, and I urge farmers and vets in Wales to make use of the considerable expertise that exists within the Wales Veterinary Science Centre and APHA."
Improve International has announced that it is to launch new 'mini-modular' courses in dentistry, oncology, neurology and ultrasound for those practitioners that want to develop a more in-depth knowledge than they would gain from a one-day course without undertaking a Certificate.
The courses, which begin in the Autumn, include two days of study each month for three months, making six days of CPD in total. Ultrasound delegates study for two days each month for two months, making four days of CPD in total. Each course, with the exception of Neurology, contains a practical element.
David Babington MRCVS, Managing Director of Improve, said: "Veterinary surgeons wanting to develop specialist skills in specific areas currently have two choices - either to embark on a full-scale Certificate programme or to attend one day sessions in their area of interest. For those without the time or resource to commit to a Certificate programme but who are keen to develop their skills to a high level, attending a one-day course may not give them the expertise - or the practical experience - they seek."
He continued: "Our Mini-Modular courses aim to bridge that gap. They are high quality programmes, led by recognised international experts, and each gives a thorough grounding in the subject, specifically geared to the requirements of the small animal general practitioner. They aim to give delegates in-depth knowledge, practical experience and the confidence to take their new skills back into practice."
The Mini-Modular courses are open to veterinary surgeons from across Europe with teaching based at Improve's training headquarters in Swindon, which offer wet-lab facilities.
For further information, visit www.improveinternational.com or call 01793 759159.
MSD Animal Health has announced the launch of Cepralock, a new teat sealant to complement its dry cow intramammary product Cepravin Dry Cow and wider Dairy Herd Health portfolio.
The company says the new product is designed for use at drying off, with or without a dry cow intramammary antibiotic, and provides an important inert barrier in the teat canal to reduce significantly the risk of bacterial infection of the udder during the dry period.
Cepralock is supplied in tubes with the option of short nozzles that are designed to help avoid the risk of teat damage and incorrect administration beyond the teat canal.
The launch is also being accompanied by dry cow therapy training and a support programme for veterinary practitioners and their dairy farmer clients. This will include diagnostics and data analytics, and training will have a significant focus on correct administration and removal of teat sealant after calving, allowing vets to provide adequate reassurances to their clients around product use.
MSD Animal Health technical adviser Martin Behr said: "The dry period is a critical time for vets as they seek to help their clients in the battle to combat mastitis, which remains a significant drain on dairy herd profitability. It provides an ideal opportunity to clear up existing bacterial infections in the udder with the use of intramammary antibiotics, but it is also vital to prevent new infections over the period.
"Cows do have their own natural physical defence against infection in the form of the keratin plug that forms in the teat canal after drying off, but this is not always sufficiently effective. In a recent study it was shown that only 50% of 500 examined quarters had a fully developed keratin plug within 10 days of drying off, whilst 20% of teats remained open into the second half of the dry period. This is significant because the majority of clinical cases of mastitis that occur during the dry period do so within the first three weeks.
"Correct use of a teat sealant at drying off, immediately after the administration of the dry cow intramammary if used, will provide an effective physical barrier for the duration of the dry period, significantly reducing the chances of new infections of the udder."
According to MSD, it is estimated that less than half of dairy cows are currently given a teat sealant at drying off, despite the concept being established for a number of years and numerous farm studies providing strong evidence of their efficacy.
Martin added: "The potential return on investment for dairy farmers of correctly applied teat sealants is clear. A single case of mastitis is estimated to cost between £70 and £250 and the average UK dairy herd suffers somewhere in the region of 50 to 60 cases per 100 cows per lactation. A correctly applied dry cow therapy programme, including the use of teat sealants, will significantly reduce the incidence of clinical mastitis, thereby providing a demonstrable return on investment.
"At MSD Animal Health we are keen to help veterinary practitioners promote best practice in dry cow therapy, including the adoption of the correct protocols and application procedures. Therefore we are supporting the launch of Cepralock with the offer of Continuous Professional Development for veterinary practitioners on all aspects of dry cow therapy, including correct use of teat sealant and its removal after calving."
Cepralock teat sealant is available to veterinary practices in packs of 24 tubes and 120 tubes.
For more information about Cepralock or MSD's Dry Cow Management Support package for vets and farmers, contact your Account Manager.
The RCVS has been recognised as one of the best places to work in the country by the Great Place To Work Institute, which carries out comprehensive annual surveys of staff engagement with a wide variety of small, medium and large businesses and organisations.
The College was ranked number 30th out of 50 in the medium (50 to 499 employees) category, after 91% of the staff gave a positive answer to the question: "Taking everything into account, I would say this is a great place to work", compared to 52% agreeing with this statement in 2013.
Nick Stace, RCVS Chief Executive, said: "The fact that we have been ranked as one of the best places to work in the country demonstrates the great strides made by the College over the past three years and recognises the resolve of staff and Council to improve our working practices, how we communicate with each other and overall well-being.
"It is also a testament to the importance of two-way communication - of giving staff the opportunity and freedom to come up with ideas and having a senior team that is willing to listen to and implement these where appropriate.
"I would also like to thank members of RCVS Council in particular as they have been very supportive of our efforts to improve staff engagement and recognise that a more motivated and happy workforce at the College will be reflected in the quality of service offered to members of the profession."
Following the award, an interview with Nick also appears in Great Workplaces, a magazine produced by Great Place to Work which is included as a supplement in the Sunday Telegraph this weekend.
Further details about steps taken by the College to improve staff engagement can be found on Nick's blog: nickstaceblogs.org
CVS has announced that it is diversifying into pet grooming, opening grooming studios in its practices across the UK.
The company says the move is in response to the large number of clients that ask its staff to recommend a groomer in their area.
The new service has been branded MiGroomers and the first four studios have been opened at The Priory Veterinary Group and The Orchard Veterinary Centre in Nottingham, at Bridge House Vets in Mansfield, and at Haygate Veterinary Centre in Telford. Further studios are opening the Old Golf House Veterinary Group in Norfolk and in the Southwold-based Fromus Veterinary Group by the end of the month.
CVS says MiGroomers studios offer a full range of grooming services, all carried out by experienced groomers, Diploma-qualified to City and Guilds Level 2 or above.
Barry Brackner, Marketing and Commercial Director at CVS, said: "Given the frequency with which we are asked to recommend local groomers, moving into this growing sector where space in our practices allows it, seems a logical next step towards providing our clients with a one-stop-shop for all of their pet care requirements.
"It also enables us to offer additional career opportunities for our staff - something which is a priority for us at CVS. All of the current MiGroomers studios are being run by existing staff with an interest and qualification in grooming so it's a win/win and initial feedback from clients has been very positive. We will open further additional MiGroomers studios where we have the interest from staff and the potential to provide the appropriate facilities."
RCVS Council member Professor the Lord Trees has today submitted a Private Members’ Bill to the ballot of the House of Lords which would legally protect the title ‘Veterinary Nurse’.
If the Bill is drawn sufficiently highly in the ballot, it will be debated in the Lords and the Commons. If approved by both Houses, it'll become law.
As it is drawn up, the Bill would prohibit use of the title ‘Veterinary Nurse’ for any person whose name is not on the RCVS Register of Veterinary Nurses. Any non-registered person who used the title Veterinary Nurse or a name, title or description that implied they were on the Register would be guilty of an offence and may be fined or convicted under the Veterinary Surgeons Act.
Lord Trees said: “It is very exciting, and a privilege, to be entering a Private Members’ Bill to protect the title veterinary nurse into the ballot for Private Members’ Bills in Parliament. If we are drawn high enough in the ballot and if we can get Parliamentary time – two important ‘ifs’ – I am confident that the Bill will receive total cross-party support.
“It would mark the final brick in the wall of creating a fully-fledged, recognised and protected veterinary nursing profession. This is what the veterinary nursing profession merits and the public deserve.”
The House of Lords ballot will be drawn before the summer recess. In the meantime, the RCVS is encouraging registered veterinary nurses to back its campaign to protect the title and raise awareness of the issue with their clients.
Further details about the campaign, including a short animated film, can be found at www.rcvs.org.uk/vntitle